|
시장보고서
상품코드
2052498
세포 표면 마커 검출 시장 : 제품별, 용도별, 지역별Cell Surface Markers Detection Market, By Product, By Application, and By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세포 표면 마커 검출 시장은 2026년에 71억 1,700만 달러로 추정되며, 2033년까지 133억 2,250만 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 9.4%로 성장할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 71억 1,700만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 9.40% | 2033년 시장 규모 예측: | 133억 2,250만 달러 |
세포 표면 마커의 검출은 유세포 분석 등의 분석 기법이나 프로세스를 이용하여 표적 세포를 분리, 식별하는 것을 말합니다. 유세포 분석과 같은 기술을 활용한 세포 표면 마커 분석은 질병 분석, 시료 분리, 질병 진단 및 후속 치료 방침 결정을 간소화할 수 있을 것으로 기대되고 있습니다.
시장 역학
질병 진단에 세포 표면 마커의 활용 확대, 암 유병률 증가, 줄기세포 연구에서의 유세포 분석법 채택 확대, 정밀 의학에 대한 수요 증가, 처리 능력 향상 및 자동화 관련 기술 발전 등이 세계 세포 표면 마커 검출 시장의 성장을 견인할 것으로 예상됩니다. 주요 요인이 될 것으로 예상됩니다.
예를 들어, 2022년 4월, 혈액학, 소변 검사, 지혈 분야의 자동화 워크플로우 솔루션 제공업체인 시스멕스 유럽은 유럽 체외진단의료기기(IVD) 규제 및 IVD 용도에 적합하다는 CE 마크를 획득한 유세포 분석기 'XF-1600'을 출시하였습니다. 이를 통해 유세포 분석 실험실을 위한 종합적인 솔루션을 구축하여 워크플로우의 자동화 및 최적화를 통해 새로운 차원의 효율성을 달성할 수 있도록 지원합니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 기업의 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 세포 표면 마커 검출 시장의 주요 기업 프로파일을 프로파일링합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 세포 표면 마커 검출 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 세포 표면 마커 검출 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 세포 표면 마커 검출 시장 : 제품별, 2021-2033년
제5장 세계의 세포 표면 마커 검출 시장 : 용도별, 2021-2033년
제6장 세계의 세포 표면 마커 검출 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 섹션
KSMCell Surface Markers Detection Market is estimated to be valued at USD 7,117.0 Mn in 2026 and is expected to reach USD 13,322.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7,117 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.40% | 2033 Value Projection: | USD 13,322.5 Mn |
Cell surface markers detection refers to separation and identification of target cells using analytical methods and processes, such as flow cytometry. Cell surface marker analysis through the usage of technologies, such as flow cytometry, is expected to simplify disease analysis, sample separation, disease diagnosis, and subsequent treatment determination.
Market Dynamics
Rise in use of cell surface markers in disease diagnostics, rise in prevalence of cancer, increasing adoption of flow cytometry in stem cell research, increasing demand for precision medicine, and technological advances related to increased throughput and automation are major factors expected to drive growth of the global cell surface markers detection market.
For instance, in April 2022, Sysmex Europe, a provider of automated workflow solutions in the disciplines of hematology, urinalysis, and hemostasis, launched Flow Cytometer XF-1600 which has received CE marking, indicating its compliance with the European IVD Regulation and IVD use; establishing a complete solution for flow cytometry laboratories to help them automate and optimize their workflow for a new level of efficiency.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cell surface markers detection market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Nexcelom Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD), Qiagen NV, Diasorin SpA (Luminex Corporation), Danaher Corporation (Beckman Coulter Inc.), and IVD Medical Holding Limited (Immucor Inc.), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cell surface markers detection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell surface markers detection market.
Market Segmentation
- Global Cell Surface Markers Detection Market, By Product (Revenue, USD Mn, 2021 - 2033)
- Flow Cytometry
- Hematology Analysers
- Cell Imaging Systems
- Reagents and Kits
- Other Products
- Global Cell Surface Markers Detection Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Disease Diagnosis and Identification
- Drug Discovery
- Other - Research and Academia Applications
- Global Cell Surface Markers Detection Market, By Geography (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Grifols SA
- Abbott Laboratories
- Sysmex Corporation
- Agilent Technologies Inc.
- Nexcelom Bioscience
- Thermo Fisher Scientific Inc.
- Siemens Healthineers
- Nihon Kohden Corporation
- F. Hoffmann-La Roche Ltd.
- Bio Rad Laboratories Inc.
- Becton, Dickinson and Company (BD)
- Qiagen NV
- Diasorin SpA (Luminex Corporation)
- Danaher Corporation (Beckman Coulter Inc.)
- IVD Medical Holding Limited (Immucor Inc.)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in use of cell surface markers disease diagnostics
- High cost of instruments and dearth of skilled professionals
- Rise in prevalence of cancer worldwide
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Cell Surface Markers Detection Market, By Product, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Hematology Analysers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Cell Imaging Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Reagents and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Other Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Cell Surface Markers Detection Market, By Application, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Disease Diagnosis and Identification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Other - Research and Academia Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Cell Surface Markers Detection Market, By Geography, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- South Africa
- North Africa
- Central Africa
7. Competitive Landscape
- Grifols SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nexcelom Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nihon Kohden Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qiagen NV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Diasorin SpA (Luminex Corporation)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation (Beckman Coulter Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IVD Medical Holding Limited (Immucor Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
8. Section
- Research Methodology
- About us
